| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 12/17/2003 | EP1370294A2 Use of natural egfr inhibitors to prevent side effects due to retinoid therapy, soaps, and other stimuli that activate the epidermal growth receptor |
| 12/17/2003 | EP1370279A2 Use of the long pentraxin ptx3 for the preparation of medicament for the prevention and cure of autoimmune pathologies |
| 12/17/2003 | EP1370276A2 Medical uses of intercellular communication facilitating compounds |
| 12/17/2003 | EP1370255A2 Cdc25 phosphatase inhibitors |
| 12/17/2003 | EP1370250A2 Flt-1 ligands and their uses in the treatment of diseases regulatable by angiogenesis |
| 12/17/2003 | EP1370241A1 Multi-lamellar emulsion(mle) for stabilizing dermatologically useful ingredients and external base preparations for general skin diseases utilizing the same |
| 12/17/2003 | EP1370233A2 Filtering composition containing a 1,3,5-triazine derivative, a dibenzoylmethane derivative, and a 4,4-diarylbutadiene compound |
| 12/17/2003 | EP1370211A2 Co-administration of melanocortin receptor agonist and phosphodiesterase inhibitor for treatment of cyclic-amp associated disorders |
| 12/17/2003 | EP1370143A2 An antimicrobial composition |
| 12/17/2003 | EP1206467B1 N-heterocyclic derivatives as nos inhibitors |
| 12/17/2003 | EP1189889B1 Compositions and methods for inhibiting cell death |
| 12/17/2003 | EP1162970B1 Anti-inflammatory uses of manzamines |
| 12/17/2003 | EP1147121B1 Ketolide antibiotics |
| 12/17/2003 | EP1082302B1 A vla-4 inhibitor: omepupa-v |
| 12/17/2003 | EP1066043B1 Materials for the treatment of conditions involving mast cells, basophils and eosinophils |
| 12/17/2003 | EP0984981B1 Anti-inflammatory tyrosine derivatives |
| 12/17/2003 | EP0937075B1 New Imidazo- and Oxazolopyridines as Phosphodiesterase Inhibitors. |
| 12/17/2003 | CN1462276A Peptide-based compounds |
| 12/17/2003 | CN1462195A Pharmaceutical compositions comprising dendritic cells for immunotherapy of automimmune disease and treatment methods using the same |
| 12/17/2003 | CN1462187A Analgesic/antiinflammatary patches for topical use |
| 12/17/2003 | CN1461650A Prescription of eliminating acne and beautifying face |
| 12/17/2003 | CN1461638A Combined antidrotic and antimicrobic composite |
| 12/17/2003 | CN1461604A Health-care food with functions of anti-senility, beautifying face and moistening skin and prepn. method therefor |
| 12/17/2003 | CN1131057C Chinese medicine fumigant for treating vulval disease and its prepn. method |
| 12/17/2003 | CN1131055C Tincture for treating leucoderma and preparation method and application thereof |
| 12/17/2003 | CN1131049C Medicine for treating psoriasis and preparation method thereof |
| 12/16/2003 | US6664264 Thioether substituted imidazoquinolines |
| 12/16/2003 | US6664247 Pyrazole compounds useful as protein kinase inhibitors |
| 12/16/2003 | US6664230 Orally administered peptides to ameliorate atherosclerosis |
| 12/16/2003 | US6664229 Methods for treatment using novel ligands of the neuropeptide receptor HFGAN72 |
| 12/16/2003 | US6664227 Treatment of fibrosis by antagonism of IL-13 and IL-13 receptor chains |
| 12/16/2003 | US6664105 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in genetically modified cells |
| 12/16/2003 | US6663900 Processed in a fluidized bed coating machine where a protective coating of a sugar or polyhydric alcohol, starch |
| 12/16/2003 | US6663878 Anti-inflammatory bioactive glass particulates |
| 12/16/2003 | US6663659 Method and apparatus for the photomodulation of living cells |
| 12/11/2003 | WO2003102138A2 Elongase genes and uses thereof |
| 12/11/2003 | WO2003101987A1 3-substituted quinuclidines and their use |
| 12/11/2003 | WO2003101981A1 Novel substituted indoles |
| 12/11/2003 | WO2003101980A1 1,3,5-triazine derivatives as ligands for human adenosine-a3 receptors |
| 12/11/2003 | WO2003101978A1 Phenyl-thiophene type vitamin d receptor modulators |
| 12/11/2003 | WO2003101970A1 Imidazolium cxcr3 inhibitors |
| 12/11/2003 | WO2003101964A1 Piperidine derivative, process for producing the same, and use |
| 12/11/2003 | WO2003101962A1 1-(aminoalkyl)-3-sulfonylindole and -indazole derivatives as 5-hydroxytryptamine-6 ligands |
| 12/11/2003 | WO2003101945A1 Ligands that are inhibitors of the rar receptors |
| 12/11/2003 | WO2003101932A2 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 12/11/2003 | WO2003101928A1 Novel ligands that are inhibitors of the rar receptors, process for preparing them and use thereof in human medicine and in cosmetics |
| 12/11/2003 | WO2003101491A1 PREVENTIVES AND/OR REMEDIES FOR SUBJECTS WITH THE EXPRESSION OR ACTIVATION OF Her2 AND/OR EGFR |
| 12/11/2003 | WO2003101479A1 Compositions for therapeutic use comprising a vitamin, a metal salt and insulin or a growth hormone |
| 12/11/2003 | WO2003101466A1 Rubrofusarin glycoside-containing composition |
| 12/11/2003 | WO2003101460A1 External preparations for treating dermatitis |
| 12/11/2003 | WO2003101456A1 Use of compounds that stimulate cgmp |
| 12/11/2003 | WO2003101413A1 Compositions containing dolichol for dermatological and cosmetic use |
| 12/11/2003 | WO2003101407A1 Use of honeysuckle extracts for producing cosmetic or dermatological preparations for the prophylaxis and treatment of inflammatory skin conditions and/or for protecting sensitive skin |
| 12/11/2003 | WO2003101392A2 Novel conazole crystalline forms and related processes, pharmaceutical compositions and methods |
| 12/11/2003 | WO2003101376A2 Topical use of at least one double-stranded rna oligonucleotide (ds rna) |
| 12/11/2003 | WO2003101375A2 Immunostimulatory oligonucleotides and uses thereof |
| 12/11/2003 | WO2003101196A1 Antimicrobial envelopes |
| 12/11/2003 | WO2003087090A3 Novel heteroaryl alkylamide derivatives useful as bradykinin receptor modulators |
| 12/11/2003 | WO2003086329A3 Skincare compositions comprising anti-oxidant agents |
| 12/11/2003 | WO2003080566A3 Hif hydroxylase inhibitors |
| 12/11/2003 | WO2003057666A3 Inhibitors of dipeptidyl peptidase iv |
| 12/11/2003 | WO2003051289A3 Solubilized topoisomerase poison agents |
| 12/11/2003 | WO2003044053A3 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 12/11/2003 | WO2003037266A3 Tetra-, penta-, hexa- and heptapeptides having antiangiogenic activity |
| 12/11/2003 | WO2003028674A3 Method for stimulating hair growth by administering vitamin d analogs |
| 12/11/2003 | WO2003027090A3 Bicyclic heterocycles as rxr ligands |
| 12/11/2003 | WO2003026579A3 Combination therapies for immune mediated diseases |
| 12/11/2003 | WO2003013569A3 Use of thrombin-derived peptides for the therapy of chronic dermal ulcers |
| 12/11/2003 | WO2003000727A3 Atopy |
| 12/11/2003 | WO2002089791A3 Acne treatment with lipooxigenase inhibitors |
| 12/11/2003 | WO2002087508A3 Nitrosated and nitrosylated nebivolol and its metabolites, compositions and methods of use |
| 12/11/2003 | WO2002078687A3 Delta-aminolevulinic acid for the therapeutical and cosmetic use |
| 12/11/2003 | WO2002078648A3 Topical composition comprising an antifungal |
| 12/11/2003 | WO2002067986A3 Symbiotic regenerative agent |
| 12/11/2003 | WO2002062778A3 Anti-thrombotic compounds, production and use thereof as medicaments |
| 12/11/2003 | WO2002043758A3 Uses of mammalian genes and related reagents |
| 12/11/2003 | US20030229148 2-aminotetralines, a process for their preparation, and pharmaceutical compositions, for the prevention and therapeutic treatment of inflammatory and/or autoimmune pathologies |
| 12/11/2003 | US20030229116 Enamine derivatives |
| 12/11/2003 | US20030229110 Cell signal transduction |
| 12/11/2003 | US20030229104 Substituted 3,4-dihydropyrido[1,2-a]pyrimidines |
| 12/11/2003 | US20030229092 Antidiabetic agents; antiinflammatory agents; analgesics; antiallergens |
| 12/11/2003 | US20030229083 Compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them |
| 12/11/2003 | US20030229067 Sedative, vasodilation, antiarrhythmia agents, antiallergens, antiinflammatory agents |
| 12/11/2003 | US20030229065 Measuring drug resistance, calibration; reducing antibiotic resistance |
| 12/11/2003 | US20030229051 Anticancer agents; restenosis; atherosclerosis; skin disorders |
| 12/11/2003 | US20030229048 Skin disorders; antiinflammatory agents |
| 12/11/2003 | US20030229047 Liquid formulation of decitabine and use of the same |
| 12/11/2003 | US20030229023 Anticancer agents; skin disorders; antiinflamamtory agents; antiarthritic agents |
| 12/11/2003 | US20030228625 Method for diagnosing and monitoring hemostatic dysfunction, severe infection and systematic inflammatory response syndrome |
| 12/11/2003 | US20030228365 Pharmaceutical formulation |
| 12/11/2003 | US20030228359 Antiallergen mixture |
| 12/11/2003 | US20030228353 Wound heraling agents; polypeptide |
| 12/11/2003 | US20030228335 Prevention, therapy of skin disorders; mixture of halogenated hydrocarbon and anhydrous lipid |
| 12/11/2003 | CA2487905A1 Use of cgmp - stimulating compounds |
| 12/11/2003 | CA2487688A1 Piperidine derivative, process for producing the same, and use |
| 12/11/2003 | CA2487678A1 Compositions for therapeutic use comprising a vitamin, a metal salt and insulin or a growth hormone |
| 12/11/2003 | CA2485871A1 1-(aminoalkyl)-3-sulfonylindole and -indazole derivatives as 5-hydroxytryptamine-6 ligands |
| 12/11/2003 | CA2485111A1 Topical use of at least one double-stranded rna oligonucleotide (ds rna) |
| 12/11/2003 | CA2484451A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 12/11/2003 | CA2483817A1 Novel ligands that are inhibitors of the rar receptors, process for preparing them and use thereof in human medicine and in cosmetics |